Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019

PURPOSE: Genetic testing is important for breast and ovarian cancer risk reduction and treatment, yet little is known about its evolving use. METHODS: SEER records of women of age ≥ 20 years diagnosed with breast or ovarian cancer from 2013 to 2017 in California or Georgia were linked to the results...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Oncol
Egile Nagusiak: Kurian, Allison W., Ward, Kevin C., Abrahamse, Paul, Bondarenko, Irina, Hamilton, Ann S., Deapen, Dennis, Morrow, Monica, Berek, Jonathan S., Hofer, Timothy P., Katz, Steven J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2021
Gaiak:
ORIGINAL REPORTS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274804/
https://ncbi.nlm.nih.gov/pubmed/33560870
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.02785
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak